欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
NL/H/0407/003
药品名称
Moxonidine 0,4 PCH
活性成分
moxonidine 0.2 mg
剂型
Film-coated tablet
上市许可持有人
Pharmachemie B.V. P.O.Box 552 2003 RN Haarlem Nederland
参考成员国 - 产品名称
Netherlands (NL)
互认成员国 - 产品名称
Belgium (BE)
United Kingdom (Northern Ireland) (XI)
许可日期
2003/08/05
最近更新日期
2024/07/01
药物ATC编码
C02AC05 moxonidine
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Multiple (Copy) Application
TypeLevel3:
Generic Article 4.8(a)(iii), first paragraph
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final Product Information
|
Moxonidine_NL_H_0407_001_003_SmPC_24_03_22_clean
Date of last change:2022/06/02
Final Product Information
|
Moxonidine_NL_H_0407_001_003_OuP_ImP_07_07_21_clean
Date of last change:2022/06/02
Final Product Information
|
Moxonidine_NL_H_0407_001_003_PIL_01_12_21_clean
Date of last change:2022/06/02
Final Labelling
|
common-outer+impack
Date of last change:2018/06/12
Final SPC
|
common-spc-clean
Date of last change:2012/10/17
Final PL
|
common-pl-clean
Date of last change:2012/10/17
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase